Glibenclamide for the Treatment of Ischemic and Hemorrhagic Stroke

Protective effect of treatment with low-dose gliclazide in a model of middle cerebral artery occlusion and reperfusion in rats

(2014) Fang Tan et al.   BRAIN RESEARCH

Exploratory Analysis of Glyburide as a Novel Therapy for Preventing Brain Swelling

(2014) Kevin N. Sheth et al.   Neurocritical Care

Trends in selection and timing of first-line pharmacotherapy in older patients with Type 2 diabetes diagnosed between 1994 and 2006

(2013) P. D. Foster et al.   DIABETIC MEDICINE

Microglia is an Active Player in How Glibenclamide Improves Stroke Outcome

(2013) Francisco J Ortega et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Sulfonylurea Receptor 1 Expression in Human Cerebral Infarcts

(2013) Rupal I. Mehta et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Glibenclamide in Cerebral Ischemia and Stroke

(2013) J. Marc Simard et al.   Neurocritical Care

Glyburide is Associated with Attenuated Vasogenic Edema in Stroke Patients

(2013) W. Taylor Kimberly et al.   Neurocritical Care

Inhibition of the Sur1-Trpm4 Channel Reduces Neuroinflammation and Cognitive Impairment in Subarachnoid Hemorrhage

(2013) Cigdem Tosun et al.   STROKE

Pilot Study of Intravenous Glyburide in Patients With a Large Ischemic Stroke

(2013) Kevin N. Sheth et al.   STROKE

Neuroprotective role of ATP-sensitive potassium channels in cerebral ischemia

(2012) Hong-shuo Sun et al.   ACTA PHARMACOLOGICA SINICA

Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas

(2012) Hagen Kunte et al.   ANNALS OF NEUROLOGY

Does inhibiting Sur1 complement rt-PA in cerebral ischemia?

(2012) J. Marc Simard et al.   Annals of the New York Academy of Sciences

Time Trends in Systemic Thrombolysis in a Large Hospital-Based Stroke Registry

(2012) O.C. Singer et al.   CEREBROVASCULAR DISEASES

ATP-dependent potassium channel blockade strengthens microglial neuroprotection after hypoxia–ischemia in rats

(2012) F.J. Ortega et al.   EXPERIMENTAL NEUROLOGY

The Sulfonylurea Receptor 1 (Sur1)-Transient Receptor Potential Melastatin 4 (Trpm4) Channel

(2012) Seung Kyoon Woo et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Glibenclamide Enhances Neurogenesis and Improves Long-Term Functional Recovery after Transient Focal Cerebral Ischemia

(2012) Francisco J Ortega et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Sulfonylurea Receptor 1 in Central Nervous System Injury: A Focused Review

(2012) J Marc Simard et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Transient receptor potential melastatin 4 and cell death

(2012) J. Marc Simard et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

Heparin Reduces Neuroinflammation and Transsynaptic Neuronal Apoptosis in a Model of Subarachnoid Hemorrhage

(2012) J. Marc Simard et al.   Translational Stroke Research

Glibenclamide—10-h Treatment Window in a Clinically Relevant Model of Stroke

(2012) J. Marc Simard et al.   Translational Stroke Research

Sequential Activation of Hypoxia-Inducible Factor 1 and Specificity Protein 1 is Required for Hypoxia-Induced Transcriptional Stimulation of Abcc8

(2011) Seung Kyoon Woo et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Craniectomy for Malignant Cerebral Infarction: Prevalence and Outcomes in US Hospitals

(2011) Brian P. Walcott et al.   PLoS One

Recombinant Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the United States

(2011) Opeolu Adeoye et al.   STROKE

Sulfonylurea Use Before Stroke Does Not Influence Outcome

(2011) Christopher G. Favilla et al.   STROKE

Metamorphosis of Subarachnoid Hemorrhage Research: from Delayed Vasospasm to Early Brain Injury

(2010) Fatima A. Sehba et al.   MOLECULAR NEUROBIOLOGY

Unfractionated Heparin: Multitargeted Therapy for Delayed Neurological Deficits Induced by Subarachnoid Hemorrhage

(2010) J. Marc Simard et al.   Neurocritical Care

Glibenclamide Is Superior to Decompressive Craniectomy in a Rat Model of Malignant Stroke

(2010) J. Marc Simard et al.   STROKE

Effect of daytime, weekday and year of admission on outcome in acute ischaemic stroke patients treated with thrombolytic therapy

(2009) M. Jauss et al.   EUROPEAN JOURNAL OF NEUROLOGY

Sulfonylurea receptors and mechanism of sulfonylurea action

(2009) U. Panten et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

De novo expression of Trpm4 initiates secondary hemorrhage in spinal cord injury

(2009) Volodymyr Gerzanich et al.   NATURE MEDICINE

Dentate gyrus and spatial behaviour

(2009) Gilberto Fernando Xavier et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

The Sulfonylurea Receptor, an Atypical ATP-Binding Cassette Protein, and Its Regulation of the K ATP Channel

(2008) Michael A. Burke et al.   CIRCULATION RESEARCH

Glibenclamide Reduces Inflammation, Vasogenic Edema, and Caspase-3 Activation after Subarachnoid Hemorrhage

(2008) J Marc Simard et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

SUR1: a unique ATP-binding cassette protein that functions as an ion channel regulator

(2008) J. Aittoniemi et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

National US Estimates of Recombinant Tissue Plasminogen Activator Use

(2008) Dawn Kleindorfer et al.   STROKE

Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1)

(2008) R. Loch Macdonald et al.   STROKE

Protective Effect of Delayed Treatment With Low-Dose Glibenclamide in Three Models of Ischemic Stroke

(2008) J. Marc Simard et al.   STROKE

Incidence and 10-Year Survival of Intracerebral Hemorrhage in a Population-Based Registry

(2008) Simona Sacco et al.   STROKE